BPG is committed to discovery and dissemination of knowledge
Citation
Wang XP, Liu C, Zhang HW, Zhai JM, Zhu JX, Sun GD, An YH, Yang HJ, Jing DS, Liu DC. H3K18 La-METTL5-CCT2 signaling axis promotes colorectal cancer progression by inhibiting pyroptosis. World J Gastroenterol 2026; 32(31): 118472 [DOI: 10.3748/wjg.118472]
Comments (1)
Andrzej S Tarnawski, MD, PhD, Professor August 24, 2026, 09:21
This study systematically elucidates the molecular mechanism by which the H3K18la METTL5–CCT2 signaling axis promotes colorectal cancer (CRC) progression by inhibiting pyroptosis. It also validated the potential of the PI3Kβ inhibitor AZD6482 to improve chemotherapy sensitivity in a high-lactate microenvironment. This study offered a novel perspective on metabolic-epigenetic regulation and the potential for targeted therapy in CRC.
Please LOGIN to submit a new comment.